Skip to Main Content

Paper Details

First-in-Human Studies of MW01-6-189WH, a Brain-Penetrant, Antineuroinflammatory Small-Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Studies in Healthy Adult Volunteers.
Clin Pharmacol Drug Dev
7
2021
Author NameAffiliation
Linda J Van EldikUniversity of Kentucky
Linda J Van EldikUniversity of Kentucky
Linda J Van EldikSpinal Cord and Brain Injury Research Center, University of Kentucky
Daniel T LaskowitzDuke University
Daniel T LaskowitzDuke Clinical Research Institute
Daniel Martin WattersonNorthwestern University
  • 1 - 6

Datasets

Release 1.2